Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

548.05
+7.791.44%
Post-market: 548.050.00000.00%19:52 EDT
Volume:1.07M
Turnover:589.66M
Market Cap:139.05B
PE:31.90
High:555.32
Open:545.10
Low:540.70
Close:540.26
52wk High:555.32
52wk Low:374.17
Shares:253.72M
Float Shares:253.72M
Volume Ratio:0.86
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.87
PE(LYR):35.77

Loading ...

Vertex Analysts Lower Their Forecasts Following Q2 Results

Benzinga Earnings
·
Aug 04

Vertex Pharmaceuticals Inc : Bofa Global Research Raises Price Objective to $605 from $600

THOMSON REUTERS
·
Aug 04

Press Release: Vertex Expands Leadership Team to Power the Next Chapter of Growth

Dow Jones
·
Aug 04

Vertex is Maintained at Outperform by Baird

Dow Jones
·
Aug 04

Vertex price target lowered to $17 from $19 at Baird

TIPRANKS
·
Aug 04

Cantor Fitzgerald Adjusts PT on Vertex Pharmaceuticals to $595 From $590, Maintains Overweight Rating

MT Newswires Live
·
Aug 04

Vertex Pharmaceuticals Inc : TD Cowen Raises Target Price to $550 from $525

THOMSON REUTERS
·
Aug 04

Analysts’ Top Technology Picks: Vertex (VERX), Life360 Shs Chess Depository Interests Repr 3 Sh (LIFX)

TIPRANKS
·
Aug 04

Vertex Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 04

Vertex Q2 2026 earnings: Cloud growth lifts adjusted EBITDA margin to 25%

TradingKey
·
Aug 04

Vertex Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance

MT Newswires Live
·
Aug 04

Vertex Q2 Adj. EPS $0.20 Beats $0.19 Estimate, Sales $203.970M Beat $202.296M Estimate

Benzinga Earnings
·
Aug 04

Vertex Q2 FY26 GAAP Net Income Rises 6% to $1.1 Billion; Revenue Increases 12% to $3.33 Billion

Reuters
·
Aug 04

GUIDANCE: (VRTX) Vertex Pharmaceuticals Now Expects 2026 Revenue Range $13.1B-$13.2B, vs. FactSet Est of $13.06B

MT Newswires Live
·
Aug 04

Vertex Raises Annual Revenue Forecast on Cystic Fibrosis Drugs Strength

Reuters
·
Aug 04

Vertex Pharmaceuticals Q2 Adj. EPS $4.73, Inline, Sales $3.334B Beat $3.232B Estimate

Benzinga Earnings
·
Aug 04

Vertex Pharmaceuticals: Guidance Continues to Include Immaterial Cost Impact from Tariffs in 2026 Based on Currently Known Tariff Rates & Regulations

THOMSON REUTERS
·
Aug 04

Vertex Pharmaceuticals Q2 EPS USD 4.31

THOMSON REUTERS
·
Aug 04

Vertex Pharmaceuticals Inc: Reiterated Its Full Year 2026 Guidance for Combined Gaap and Non-Gaap R&D, Aipr&D, and SG&a Expenses

THOMSON REUTERS
·
Aug 04